IBDEI1L6 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26897,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,26897,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,26897,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,26898,0)
 ;;=F16.259^^100^1294^8
 ;;^UTILITY(U,$J,358.3,26898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26898,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/ Mod/Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,26898,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,26898,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,26899,0)
 ;;=F16.959^^100^1294^9
 ;;^UTILITY(U,$J,358.3,26899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26899,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic Disorder w/o Use Disorder
 ;;^UTILITY(U,$J,358.3,26899,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,26899,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,26900,0)
 ;;=F16.99^^100^1294^20
 ;;^UTILITY(U,$J,358.3,26900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26900,1,3,0)
 ;;=3^Phencyclidine Use Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,26900,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,26900,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,26901,0)
 ;;=F11.10^^100^1295^23
 ;;^UTILITY(U,$J,358.3,26901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26901,1,3,0)
 ;;=3^Opioid Use Disorder,Mild
 ;;^UTILITY(U,$J,358.3,26901,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,26901,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,26902,0)
 ;;=F11.129^^100^1295^19
 ;;^UTILITY(U,$J,358.3,26902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26902,1,3,0)
 ;;=3^Opioid Intoxication w/o Perceptual Disturbances;Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,26902,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,26902,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,26903,0)
 ;;=F11.14^^100^1295^27
 ;;^UTILITY(U,$J,358.3,26903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26903,1,3,0)
 ;;=3^Opioid-Induced Depressive Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,26903,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,26903,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,26904,0)
 ;;=F11.182^^100^1295^29
 ;;^UTILITY(U,$J,358.3,26904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26904,1,3,0)
 ;;=3^Opioid-Induced Sleep Disorder w/ Mild Use Disorder
 ;;^UTILITY(U,$J,358.3,26904,1,4,0)
 ;;=4^F11.182
 ;;^UTILITY(U,$J,358.3,26904,2)
 ;;=^5003124
 ;;^UTILITY(U,$J,358.3,26905,0)
 ;;=F11.20^^100^1295^24
 ;;^UTILITY(U,$J,358.3,26905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26905,1,3,0)
 ;;=3^Opioid Use Disorder,Moderate-Severe
 ;;^UTILITY(U,$J,358.3,26905,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,26905,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,26906,0)
 ;;=F11.21^^100^1295^25
 ;;^UTILITY(U,$J,358.3,26906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26906,1,3,0)
 ;;=3^Opioid Use Disorder,Moderate-Severe,In Remission
 ;;^UTILITY(U,$J,358.3,26906,1,4,0)
 ;;=4^F11.21
 ;;^UTILITY(U,$J,358.3,26906,2)
 ;;=^5003128
 ;;^UTILITY(U,$J,358.3,26907,0)
 ;;=F11.23^^100^1295^26
 ;;^UTILITY(U,$J,358.3,26907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26907,1,3,0)
 ;;=3^Opioid Withdrawal
 ;;^UTILITY(U,$J,358.3,26907,1,4,0)
 ;;=4^F11.23
 ;;^UTILITY(U,$J,358.3,26907,2)
 ;;=^5003133
 ;;^UTILITY(U,$J,358.3,26908,0)
 ;;=F11.24^^100^1295^28
 ;;^UTILITY(U,$J,358.3,26908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26908,1,3,0)
 ;;=3^Opioid-Induced Depressive Disorder w/ Moderate-Severe Use Disorder
 ;;^UTILITY(U,$J,358.3,26908,1,4,0)
 ;;=4^F11.24
 ;;^UTILITY(U,$J,358.3,26908,2)
 ;;=^5003134
 ;;^UTILITY(U,$J,358.3,26909,0)
 ;;=F11.29^^100^1295^2
 ;;^UTILITY(U,$J,358.3,26909,1,0)
 ;;=^358.31IA^4^2
